Urologic Oncologist at Cleveland Clinic Weston Hospital, Alberto Pieretti, MD, joins the Cancer Advances Podcast to talk about how innovations in imaging, biomarkers and multidisciplinary care are reshaping the diagnosis and management of prostate cancer. Hear how advances such as PSMA PET scans, biomarker-guided biopsies and precision therapies are improving outcomes and quality of life for patients.
All content for Cleveland Clinic Cancer Advances is the property of Cleveland Clinic Taussig Cancer Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Urologic Oncologist at Cleveland Clinic Weston Hospital, Alberto Pieretti, MD, joins the Cancer Advances Podcast to talk about how innovations in imaging, biomarkers and multidisciplinary care are reshaping the diagnosis and management of prostate cancer. Hear how advances such as PSMA PET scans, biomarker-guided biopsies and precision therapies are improving outcomes and quality of life for patients.
Management of Clinically Node-Negative Salivary Gland Cancer
Cleveland Clinic Cancer Advances
19 minutes
3 months ago
Management of Clinically Node-Negative Salivary Gland Cancer
Brian Burkey, MD, MEd, Interim Director of the Scully Walsh Cancer Center and Division Chair of Otolaryngology Head and Neck Surgery at Cleveland Clinic in Florida, joins the Cancer Advances Podcast to talk about management strategies for clinically node-negative salivary gland cancer. Listen as Dr. Burkey highlights findings from an outcomes study and share strategies to better identify high-risk patients who may benefit from more aggressive treatment.
Cleveland Clinic Cancer Advances
Urologic Oncologist at Cleveland Clinic Weston Hospital, Alberto Pieretti, MD, joins the Cancer Advances Podcast to talk about how innovations in imaging, biomarkers and multidisciplinary care are reshaping the diagnosis and management of prostate cancer. Hear how advances such as PSMA PET scans, biomarker-guided biopsies and precision therapies are improving outcomes and quality of life for patients.
